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The endocannabinoid system is a unique neuromodulatory
system in mammalian physiology. It consists of cannabinoid
receptors (CB1 and CB2), their endogenous lipid ligands
[endocannabinoids, including anandamide (AEA), and
2-arachidonoylglycerol (2-AG)] and the enzymes for ligand
synthesis and degradation. In recent years, brain endocannabi-
noids have emerged as key modulators of affect, motivation and
emotions, and the endocannabinoid system is nowadays consid-
ered an intriguing target for the development of selective and
specific compounds able to treat several psychiatric disorders.
This e-book brings together leading experts in the field to provide
a deep overview of the physiological and pathophysiological role
of the endocannabinoid system in the modulation of emotions
and cognition.
The e-book opens with a review where Battista et al. pro-
vide a general overview on the endocannabinoid system and
then focus on the metabolic and signal transduction pathways
of the main endocannabinoids, AEA and 2-AG. At the end, the
authors briefly discuss the therapeutic potential of new cannabi-
noid drugs (Battista et al., 2012). This issue is further elaborated
in the following review, where Marco et al. provide both clinical
and preclinical evidence supporting the involvement of the endo-
cannabinoid system in several neuropsychiatric disorders (Marco
et al., 2011).
The role of the endocannabinoid system in the modulation of
emotions and cognition is widely underscored by several reviews
of this e-book. Zanettini et al. broadly introduce this topic by
discussing the results of studies performed in laboratory ani-
mals (Zanettini et al., 2011), while Rubino and Parolaro address
this issue from a sexually-dimorphic perspective (Rubino and
Parolaro, 2011).
The original research article by Terzian et al. investigated the
potential cross-talk between dopaminergic and cannabinoid neu-
rotransmission in the modulation of emotions and cognition
(Terzian et al., 2011). The authors showed that conditional CB1
receptor knock-out animals lacking CB1 cannabinoid receptors
in neurons expressing D1dopamine receptors exhibited signifi-
cantly increased contextual and auditory-cued fear compared to
wild-type animals, suggesting that a specific reduction of endo-
cannabinoid signaling in neurons expressing dopamineD1 recep-
tor is able to affect acute fear adaptation (Terzian et al., 2011). In
their commentary on this research article, Akirav and Fattore dis-
cuss about the potential clinical implication of these findings, and
indicate the future directions for research in this field (Akirav and
Fattore, 2011).
The preclinical studies reviewed by Trezza and co-workers
show that cannabinoid modulation of emotionality and cognitive
performance appears since early developmental stages; indeed,
evidence has been provided over the last few years that animals
exposed to cannabinoid drugs during the perinatal, prenatal or
adolescent period show long-lasting changes in emotional reac-
tivity and cognitive processing (Campolongo et al., 2007, 2009,
2011; Trezza et al., 2012).
The effects of cannabinoid drugs on hippocampal memory
and plasticity are discussed by Akirav (Akirav, 2011); on the
basis of the existing literature, she concludes that these effects
may vary depending on the route of drug administration, the
nature of the task used, whether it involves emotional or non-
emotional memory formation, and according to the memory
stage under investigation (acquisition, consolidation, retrieval,
and extinction) and the brain areas involved (Akirav, 2011).
To study the role of CB1 cannabinoid receptors in the medial
prefrontal cortex on cognitive flexibility and emotional behavior
in rats, Klugmann et al. upregulated CB1 cannabinoid recep-
tors selectively in this brain area by using adeno-associated
viral vector-mediated gene transfer (Klugmann et al., 2011). In
their research article, these authors showed that upregulation
of CB1 receptors specifically in the rat medial prefrontal cortex
induces alterations in emotional reactivity, leads to inadequate
social behavior, and impairs cognitive flexibility (Klugmann et al.,
2011). In the following research article published on this e-book,
Hernandez et al. shed more light on the role of CB1 cannabinoid
receptors in mediating reward-seeking behaviors (Hernandez
et al., 2011). In particular, the authors showed that, unlike lithium
chloride, the CB1 receptor antagonist AM251 did not affect
instrumental responding for brain stimulation reward. On the
basis of these findings, the authors hypothesize that endocannabi-
noids are primarily involved with the motivational rather than the
intrinsic aspects of reward processing (Hernandez et al., 2011).
The last three articles included in this e-book address the
topic of cannabinoidmodulation of emotions and cognition from
a clinical perspective. The first of these studies is a research
article where Spronk and colleagues showed that the active
ingredient of Cannabis 9-tetrahydrocannabinol (THC) alters
performance monitoring, that is a process that allows humans to
respond actively and safely to changing environmental demands
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(Spronk et al., 2011). This study supports the opinion that
Cannabis use during performance of complex functions like driv-
ing, which require a high level of performance monitoring, might
be particularly risky. Fattore and Fratta address a very hot and
timely topic, that is the availability of a new generation of drugs
that, although devoid of tobacco or Cannabis, when smoked
produce effects similar to those induced by THC (Fattore and
Fratta, 2011). The authors first outline the general characteris-
tics of these drugs, such as their content and their effects, and
then address the consequences that their use has for both health
and society (Fattore and Fratta, 2011). The last contribution to
this e-book is the opinion article by Bhattacharyya and Sendt,
that provides evidence from neuroimaging studies that cannabi-
noid drugs affect brain areas involved in cognitive and emotional
processes (Bhattacharyya and Sendt, 2012).
Altogether, the collection of articles included in this e-book
demonstrates that endocannabinoids play a crucial role in the
regulation of emotionality and cognitive performance, as out-
lined by both rodent and human studies. We hope that it will
be apparent to the readers how far we have come in recent
years in understanding the functions of brain endocannabi-
noids in both physiological and pathological conditions, and
which are the current challenges for researchers working in this
field.
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